A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
Clinical trial NCT07376720 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07376720
- Sponsor
- Donghua Zhang
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-15
- Primary completion
- 2028-10-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.